Skip to main content

NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.

Publication ,  Journal Article
Adelstein, D; Gillison, ML; Pfister, DG; Spencer, S; Adkins, D; Brizel, DM; Burtness, B; Busse, PM; Caudell, JJ; Cmelak, AJ; Colevas, AD ...
Published in: J Natl Compr Canc Netw
June 2017

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Head and Neck Cancers provide treatment recommendations for cancers of the lip, oral cavity, pharynx, larynx, ethmoid and maxillary sinuses, and salivary glands. Recommendations are also provided for occult primary of the head and neck (H&N), and separate algorithms have been developed by the panel for very advanced H&N cancers. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding the increase in human papillomavirus-associated oropharyngeal cancer and the availability of immunotherapy agents for treatment of patients with recurrent or metastatic H&N cancer.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

June 2017

Volume

15

Issue

6

Start / End Page

761 / 770

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Humans
  • Head and Neck Neoplasms
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Adelstein, D., Gillison, M. L., Pfister, D. G., Spencer, S., Adkins, D., Brizel, D. M., … Darlow, S. D. (2017). NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017. J Natl Compr Canc Netw, 15(6), 761–770. https://doi.org/10.6004/jnccn.2017.0101
Adelstein, David, Maura L. Gillison, David G. Pfister, Sharon Spencer, Douglas Adkins, David M. Brizel, Barbara Burtness, et al. “NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.J Natl Compr Canc Netw 15, no. 6 (June 2017): 761–70. https://doi.org/10.6004/jnccn.2017.0101.
Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, et al. NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017. J Natl Compr Canc Netw. 2017 Jun;15(6):761–70.
Adelstein, David, et al. “NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.J Natl Compr Canc Netw, vol. 15, no. 6, June 2017, pp. 761–70. Pubmed, doi:10.6004/jnccn.2017.0101.
Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Lydiatt WM, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD. NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017. J Natl Compr Canc Netw. 2017 Jun;15(6):761–770.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

June 2017

Volume

15

Issue

6

Start / End Page

761 / 770

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Humans
  • Head and Neck Neoplasms
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis